share_log

东方生物(688298.SH):呼吸道三联检产品获得美国FDA EUA授权

Zhejiang Orient Gene Biotech (688298.SH): Respiratory tract triple detection products obtained USA FDA EUA authorization.

Zhitong Finance ·  Jun 11 16:41

Zhejiang Orient Gene Biotech (688298.SH) announced that its wholly-owned subsidiary, USA HealthGene Biotech Ltd. (referred to as "USA HealthGene" or "the Company") has recently obtained Emergency Use Authorization (EUA) for Healgen COVID-19/Flu A&B Ag Combo Rapid Test Cassette (Swab) approved by the U.S. Food & Drug Administration (FDA).

This product has obtained the USA FDA EUA authorization, further improving the company's important product categories in the USA market, which is conducive to the overall expansion of the USA market. The company will continue to pay attention to the demand dynamics of the USA market and actively promote the market sales of this product.

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment